Does VEDOLIZUMAB Cause Rebound effect? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Rebound effect have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.0% of all adverse event reports for VEDOLIZUMAB.
9
Reports of Rebound effect with VEDOLIZUMAB
0.0%
of all VEDOLIZUMAB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Rebound effect From VEDOLIZUMAB?
Of the 9 reports, 5 (55.6%) required hospitalization.
Is Rebound effect Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Rebound effect?
OMEPRAZOLE (2,335)
DUPILUMAB (2,192)
LANSOPRAZOLE (1,561)
ESOMEPRAZOLE (1,493)
PANTOPRAZOLE (956)
PREDNISONE (806)
DEXLANSOPRAZOLE (572)
DENOSUMAB (478)
FINGOLIMOD (379)
NIRMATRELVIR\RITONAVIR (342)
Which VEDOLIZUMAB Alternatives Have Lower Rebound effect Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB